Key result
Oral alprenolol was evaluated at doses of 200, 400, and 800 mg/day in a cross-over trial of 17 patients with typical angina pectoris, though the abstract reports no clinical results.
Key points are not available for this paper at this time.
No clinical outcomes reported from this small crossover trial; leaves open alprenolol efficacy in angina.
Seventeen patients with typical angina pectoris have been given alprenolol in a randomized double-blind cross-over trial. The drug was given twice daily in a total dosage of 200 mg/day, 400 mg/day, and 800 mg/day over 2-week periods, so that the total trial (excluding the run-in period) covered 3 months.
No takes yet. Share an insight, caveat, or question.
Sowton et al. (1971) studied this question. Oral alprenolol was evaluated at doses of 200, 400, and 800 mg/day in a cross-over trial of 17 patients with typical angina pectoris, though the abstract reports no clinical results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: